SKA3 Expression as a Prognostic Factor for Patients with Pancreatic Adenocarcinoma

Karolina Buchholz1,2, Justyna Durślewicz1, Anna Klimaszewska-Wiśniewska1

  • 1Department of Clinical Pathomorphology, Faculty of Medicine, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, 85-094 Bydgoszcz, Poland.